Neurogene NGNE
$25.31 −$0.34 (-1.33%)
Market closed · Nov 6, 8:20 pm ET · Last extended-hours $25.31 0.00%
Open$26.33
Prev close$25.65
Day range$24.68 – $27.26
Volume324.9K
Market cap$506.49M
P/E (TTM)–
Dividend yield–
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Institutional ownership97.5%-15.72 pts vs. prior quarter
Institutions holding150+7 vs. prior quarter
Insider trades (recent)37 buys / 11 sellsNet buying
Short interest25.45% of floatDays to cover 14.4 · as of 15 Oct 2026
Short-sale volume share25.0%5-day average of daily volume
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$1.03M (4 inflow days, 16 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 41.3% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 15.57% to 25.45% of float over the last 6 biweekly reports (31 Jul 2026 to 15 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Jennison Associates LLC | Mutual Fund | 2026/Q3 | +1,710,500 | 11.1% |
| Rachel McMinn | Individual/Insider | 2026/Q3 | +26,656 | 6.6% |
| Man Investment Partners (US) LP | Mutual Fund | 2026/Q3 | +24,669 | 0.1% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +23,857 | 0.1% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +204,234 | 1.0% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +141,920 | 0.7% |
| Moore Capital Management, LP | Hedge Fund | 2026/Q3 | +141,636 | 0.7% |
| Casdin Capital, LLC | VC/PE Fund | 2026/Q3 | +125,000 | 7.7% |
| Driehaus Capital Management LLC | Mutual Fund | 2026/Q3 | +110,763 | 0.7% |
| Balyasny Asset Management L.P. | Hedge Fund | 2026/Q3 | +100,317 | 4.1% |
| Trexquant Investment LP | Hedge Fund | 2026/Q3 | +73,762 | 0.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +52,913 | 5.3% |
| Dafna Capital Management, LLC | Hedge Fund | 2026/Q3 | +32,397 | 0.4% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +31,393 | 0.2% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +30,521 | 0.5% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 21 Sep 2026 | Rachel McMinn | Founder, Executive Chair & CEO | Derivative Exercise and Retained | +756 | $25.32 | 1,329,130 |
| 6 Jul 2026 | Christine Cvijic | Chief Financial Officer | Automatic Disposition | -4,800 | $36.13 | 37,872 |
| 1 Jul 2026 | Christine Cvijic | Chief Financial Officer | Automatic Disposition | -4,800 | $35.23 | 42,672 |
| 5 May 2026 | Christine Cvijic | Chief Financial Officer | Automatic Disposition | -9,600 | $32.44 | 47,472 |
| 4 May 2026 | Christina Shafer | Chief Commercial Officer | Other Derivative Acquisition | +120,000 | $28.94 | 120,000 |
| 25 Mar 2026 | Rachel McMinn | Founder, Executive Chair & CEO | Open Market Disposition | -3,352 | $22.07 | 1,302,474 |
| 25 Mar 2026 | Christine Cvijic | Chief Financial Officer | Open Market Disposition | -2,558 | $21.62 | 57,072 |
| 25 Mar 2026 | Julie Jordan | Chief Medical Officer | Open Market Disposition | -828 | $21.89 | 3,605 |
| 12 Mar 2026 | Christine Cvijic | Chief Financial Officer | Open Market Disposition | -4,045 | $22.02 | 52,863 |
| 12 Mar 2026 | Stuart Cobb | Chief Scientific Officer | Automatic Disposition | -6,797 | $22.08 | – |
| 26 Feb 2026 | Christine Cvijic | Chief Financial Officer | Automatic Disposition | -4,800 | $25.11 | 46,274 |
| 19 Feb 2026 | Robert Baffi | Independent Director | Other Derivative Acquisition | +12,050 | $17.64 | 12,050 |
| 19 Feb 2026 | Rohan Palekar | Independent Director | Other Derivative Acquisition | +12,050 | $17.64 | 12,050 |
| 19 Feb 2026 | Rachel McMinn | Founder, Executive Chair & CEO | Other Acquisition | +25,900 | – | 49,800 |
| 19 Feb 2026 | Rachel McMinn | Founder, Executive Chair & CEO | Other Derivative Acquisition | +155,100 | $17.64 | 155,100 |
| 19 Feb 2026 | Sarah Noonberg | Independent Director | Other Derivative Acquisition | +12,050 | $17.64 | 12,050 |
| 19 Feb 2026 | Christine Cvijic | Chief Financial Officer | Other Acquisition | +22,000 | – | 63,569 |
| 19 Feb 2026 | Christine Cvijic | Chief Financial Officer | Other Derivative Acquisition | +131,900 | $17.64 | 131,900 |
| 19 Feb 2026 | Cory Freedland | Lead Independent Director | Other Derivative Acquisition | +12,050 | $17.64 | 12,050 |
| 19 Feb 2026 | Robert Woods | Independent Director | Other Derivative Acquisition | +12,050 | $17.64 | 12,050 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 5,093,623 | 25.5% | 14.4 |
| 30 Sep 2026 | 4,974,749 | 24.9% | 11.7 |
| 15 Sep 2026 | 3,280,172 | 16.4% | 16.9 |
| 31 Aug 2026 | 3,135,369 | 15.7% | 13.6 |
| 14 Aug 2026 | 3,038,441 | 15.2% | 16.8 |
| 31 Jul 2026 | 3,005,232 | 15.6% | 16.2 |
No comments yet — be the first to weigh in on NGNE.
Sign in to join the discussion.